NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. Week of Oct. 8.Allogene Therapeutics - San Francisco, 16 million shares, priced $16-$18, managed by Goldman Sachs/J.P. Morgan. Proposed Nasdaq symbol ALLO. Business: Phase 1 biotech developing off-the-shelf CAR T cell therapies. Alzheon - Framingham, Mass., 2.5 million shares, priced $13-$15, managed by ThinkEquity/H.C. Wainwright. Proposed Nasdaq symbol ALZH. Business: Phase 3 biotech developing small molecule therapies for therapies for Alzheimer's disease.